Newsletter
Newsletter

Genetic Modifiers for Treatment in Lysosomal Disorders

by | Jan 15, 2025

Andrés Klein, PhD, Associate Professor and Director of the Doctorate Program in Sciences and Innovation in Medicine at Universidad del Desarrollo, Santiago, Chile, discusses the identification of genetic modifiers for treatment in lysosomal disorders.    ...

Gaucher Community Alliance

by | Jan 14, 2025

Madelyn Schloss, Social Media and Development Associate for Gaucher Community Alliance, discusses the organization.     The Gaucher Community Alliance is a non-profit organization run by patients with Gaucher disease, offering advocacy, education, patient...

Autophagy–Lysosomal Systems in Parkinson’s Disease

by | Jan 13, 2025

Juozas Gordevicius, PhD, Chief Technology Officer of VUGENE Vilnius, Lithuania, discusses  autophagy-lysosomal systems in Parkinson’s disease.     Parkinson’s disease is a neurological disorder causing unintended or uncontrollable movements, such as shaking,...

Hypoparathyroidism

by | Jan 12, 2025

Hypoparathyroidism is a rare endocrine disorder characterized by a deficiency of parathyroid hormone (PTH), which leads to decreased serum calcium and increased phosphorus levels in the blood.   Etiology The most common cause of hypoparathyroidism is unintended...